Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2491632rdf:typepubmed:Citationlld:pubmed
pubmed-article:2491632lifeskim:mentionsumls-concept:C0231335lld:lifeskim
pubmed-article:2491632lifeskim:mentionsumls-concept:C0566602lld:lifeskim
pubmed-article:2491632lifeskim:mentionsumls-concept:C0241910lld:lifeskim
pubmed-article:2491632lifeskim:mentionsumls-concept:C1148673lld:lifeskim
pubmed-article:2491632lifeskim:mentionsumls-concept:C0311474lld:lifeskim
pubmed-article:2491632pubmed:issue4lld:pubmed
pubmed-article:2491632pubmed:dateCreated1991-10-21lld:pubmed
pubmed-article:2491632pubmed:abstractTextAutoimmune chronic active hepatitis (aCAH) and primary sclerosing cholangitis (PSC) are liver disorders occurring in childhood in which non-organ specific autoantibodies, such as anti-nuclear antibody (ANA) are frequently found. Antibodies to double stranded DNA (dsDNA), which are typically present in systemic lupus erythematosus (SLE), have been detected in both acute and chronic liver diseases in adults. In this study, using a radioimmunoassay technique widely employed to measure antibodies to dsDNA, we have demonstrated significantly increased levels (median and range; 11.9, 1.0-36.5 U/ml) in 21 children with aCAH compared with normal children (1.0, 0.7-2.1 U/ml; p less than 0.01). Five children with aCAH had levels in the range considered diagnostic for SLE (greater than 25 U/ml) and of these, three had ANA and two had anti-liver kidney microsomal antibody. In addition, one child had antibodies to dsDNA as detected by the Crithidia luciliae test. DNA binding in aCAH was correlated with serum aspartate-amino transferase levels (r = 0.68; p less than 0.001), suggesting a direct relationship with disease activity. In PSC, levels of antibodies to dsDNA were significantly increased compared to normal controls (median and range; 7.0, 5.6-10.2 U/ml; p less than 0.01) but were not as high as those found in aCAH.lld:pubmed
pubmed-article:2491632pubmed:languageenglld:pubmed
pubmed-article:2491632pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2491632pubmed:citationSubsetIMlld:pubmed
pubmed-article:2491632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2491632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2491632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2491632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2491632pubmed:statusMEDLINElld:pubmed
pubmed-article:2491632pubmed:issn0891-6934lld:pubmed
pubmed-article:2491632pubmed:authorpubmed-author:MowatA PAPlld:pubmed
pubmed-article:2491632pubmed:authorpubmed-author:VerganiDDlld:pubmed
pubmed-article:2491632pubmed:authorpubmed-author:Mieli-Vergani...lld:pubmed
pubmed-article:2491632pubmed:authorpubmed-author:PeakmanMMlld:pubmed
pubmed-article:2491632pubmed:authorpubmed-author:BevisLLlld:pubmed
pubmed-article:2491632pubmed:issnTypePrintlld:pubmed
pubmed-article:2491632pubmed:volume3lld:pubmed
pubmed-article:2491632pubmed:ownerNLMlld:pubmed
pubmed-article:2491632pubmed:authorsCompleteYlld:pubmed
pubmed-article:2491632pubmed:pagination271-80lld:pubmed
pubmed-article:2491632pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:meshHeadingpubmed-meshheading:2491632-...lld:pubmed
pubmed-article:2491632pubmed:year1989lld:pubmed
pubmed-article:2491632pubmed:articleTitleDouble stranded DNA binding in autoimmune chronic active hepatitis and primary sclerosing cholangitis starting in childhood.lld:pubmed
pubmed-article:2491632pubmed:affiliationDepartment of Immunology, King's College School of Medicine and Dentistry, Denmark Hill, London.lld:pubmed
pubmed-article:2491632pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2491632pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed